Who Should Not Use GLP-1 Medications According to standard clinical guidelines and prescribing information, GLP-1 medications may not be appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Have multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) Are pregnant, planning to become pregnant, or breastfeeding Have a history of severe allergic reactions to semaglutide, tirzepatide, or any inactive ingredients This is not a replacement for prescribed medical treatment for any health condition
Injectable semaglutide (Ozempic, Wegovy) is administered weekly via subcutaneous injection
If UTI becomes recurrent, your PlexusDx provider may recommend the Precision Peptide Genetic Test ($99 add-on) to identify underlying genetic predispositions and adjust your treatment plan accordingly
"The approval of Wegovy represents a turning point for healthcare providers to embrace medical management of obesity to help improve chronic weight management for patients." What Are the Common Side Effects
This makes you feel full for too long
